Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Aaron Kelly currently holds 65,590 shares of NEOGENOMICS INC (NEO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Aaron Kelly has been a net neutral trader of NEO stock. They have purchased $0 and sold $0 worth of shares.
Michael Aaron Kelly's most recent insider trade was on May 13, 2026, when they sold 16,937 shares at $0.00 per share.
Michael Aaron Kelly serves as Executive at NEOGENOMICS INC (NEO). They have executed 22 insider transactions totaling $0 over their tenure at the company.
Michael Aaron Kelly holds the position of Executive at NEOGENOMICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Michael Aaron Kelly has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Michael Aaron Kelly was on May 13, 2026, when they purchased $0 worth of BOOM shares. This transaction involved 16,937 shares at N/A per share.
Michael Aaron Kelly currently owns 65,590 shares of NEOGENOMICS INC (NEO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Aaron Kelly's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Aaron Kelly has 22 Form 4 filings on record as an insider at NEOGENOMICS INC.
Set alerts for Michael Aaron Kelly and 40,000+ other insiders.